Catégorie
Canagliflozin
Numéro CAS
842133-18-0
Autre numéro CAS
928672-86-0(Hemihydrate)
Formule moléculaire
C24H25FO5S
Masse moléculaire
444.52 g/mol
Synonyme

(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol; (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol

Mots-clés
Aromatics
Heterocycles
Enzyme inhibitors
Pharmaceutical Standards
Intermediates
Fine Chemicals
sulphur and selenium compounds
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Canagliflozin is a standard oral antidiabetic agent from the SGLT2 inhibitor class used in the management of type 2 diabetes mellitus. It acts by inhibiting glucose reabsorption in the kidneys, leading to increased urinary glucose excretion and improved glycemic control independent of insulin. In addition to lowering blood glucose, canagliflozin has demonstrated cardiovascular and renal protective benefits, making it a well-established option in current diabetes treatment guidelines.